![Jon Kayyem](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jon Kayyem
Direktor/Vorstandsmitglied bei
BIODESIX, INC.
Vermögen: 110 Mio $ am 31.05.2026
Profil
Jon Faiz Kayyem was the founder of GenMark Diagnostics, Inc. (1993) serving as Senior Vice President-Research & Development; Clinical Micro Sensors, Inc. (1995); Efficacy Capital Ltd. (2004) serving as Managing Partner from 2004 to 2009; and Calimmune, Inc. (2006) serving as Director from 2006 to 2017.
Current jobs include Independent Director at Biodesix, Inc. since 2021, Independent Director at Inhibrx Biosciences, Inc. since 2024, and Trustee at California Institute of Technology since 2006.
Former jobs include Chief Executive Officer at Osmetech Ltd. from 2009 to 2010, Independent Director at Sanofi AATD, Inc. from 2018 to 2024, and Vice President-Life Sciences at Motorola, Inc. from 2000 to 2004.
Education includes undergraduate and graduate degrees from Yale University in 1984 and 1985, respectively, and a doctorate from California Institute of Technology in 1991.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
7,22 % | 03.06.2026 | 1.059.046 ( 7,22 % ) | 110 Mio $ | 31.05.2026 |
BIODESIX, INC. 0,22 % | 04.03.2026 | 17.876 ( 0,22 % ) | 291 736 $ | 31.05.2026 |
Aktive Positionen von Jon Kayyem
| Unternehmen | Position | Beginn |
|---|---|---|
| BIODESIX, INC. | Direktor/Vorstandsmitglied | 06.12.2021 |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | 30.09.2011 |
Ehemalige bekannte Positionen von Jon Kayyem
| Unternehmen | Position | Ende |
|---|---|---|
| INHIBRX, INC. | Direktor/Vorstandsmitglied | 30.05.2024 |
| GENMARK DIAGNOSTICS, INC. | Vorstandsvorsitzender | 01.02.2018 |
Calimmune, Inc.
 Calimmune, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Gründer | 01.01.2017 |
Osmetech Ltd.
 Osmetech Ltd. Medical/Nursing ServicesHealth Services Design, development, manufacture and sale of molecular diagnostics instruments and consumables enabling | Vorstandsvorsitzender | 01.05.2010 |
Efficacy Capital Ltd. | Gründer | 01.09.2009 |
Ausbildung von Jon Kayyem
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
91
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Motorola, Inc.
 Motorola, Inc. Telecommunications EquipmentElectronic Technology Develops communication and electronic solutions | Electronic Technology |
Efficacy Capital Ltd. | |
Biodesix, Inc.
 Biodesix, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic research and clinical trial testing services & engages in discovery, development and commercialization of therapeutics | Health Services |
GenMark Diagnostics, Inc.
 GenMark Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops and commercializes immunoassays, serology, molecular & tissue diagnostic testing systems | Health Technology |
Osmetech Ltd.
Osmetech Ltd. Medical/Nursing ServicesHealth Services Design, development, manufacture and sale of molecular diagnostics instruments and consumables enabling | Health Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clinical Micro Sensors, Inc.
 Clinical Micro Sensors, Inc. Electronic Equipment/InstrumentsElectronic Technology Manufactures instruments used in genetic diagnostics testing | Electronic Technology |
Calimmune, Inc.
Calimmune, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Inhibrx, Inc.
 Inhibrx, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops biologic therapeutics for the treatment of cancer | Health Technology |
Wählen Sie MarketScreener 
